Cited by 241Liver physiology and pathologyLiver Disease Diagnosis and TreatmentCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

A High-Cholesterol Diet Exacerbates Liver Fibrosis in Mice via Accumulation of Free Cholesterol in Hepatic Stellate Cells

Open access

Teratani, Toshiaki, Tomita, Kengo, Suzuki, Takahiro, Oshikawa, Tetsuya, Yokoyama, Hirokazu, Shimamura, Katsuyoshi, Tominaga, Susumu, Hiroi, Sadayuki, Irie, Rie, Okada, Yoshikiyo, Kurihara, Chie, Ebinuma, Hirotoshi, Saito, Hidetsugu, Hokari, Ryota, Sugiyama, Kazuo, Kanai, Takanori, Miura, Soichiro, Hibi, Toshifumi·2012·Gastroenterology

DOI 10.1053/j.gastro.2011.09.049

Open this paper in CoChat — free account Open PDF

Abstract

Background & aims Some studies have indicated that dietary cholesterol has a role in the progression of liver fibrosis. We investigated the mechanisms by which dietary cholesterol might contribute to hepatic fibrogenesis.Methods C57BL/6 mice were fed a high-cholesterol diet or a control diet for 4 weeks; liver fibrosis then was induced by bile-duct ligation or carbon tetrachloride administration. Hepatic stellate cells (HSCs) were isolated from mice fed high-cholesterol diets or from Niemann-Pick type C1-deficient mice, which accumulate intracellular free cholesterol.Results After bile-duct ligation or carbon tetrachloride administration, mice fed high-cholesterol diets had significant increases in liver fibrosis and activation of HSCs compared with mice fed control diets. There were no significant differences in the degree of hepatocellular injury or liver inflammation, including hepatocyte apoptosis or Kupffer cell activation, between mice fed high-cholesterol or control diets. Levels of free cholesterol were much higher in HSCs from mice fed high-cholesterol diets than those fed control diets. In cultured HSCs, accumulation of free cholesterol in HSCs increased levels of Toll-like receptor 4 (TLR4), leading to down-regulation of bone morphogenetic protein and activin membrane-bound inhibitor (a pseudoreceptor for transforming growth factor [TGF]β); the HSCs became sensitized to TGFβ-induced activation. Liver fibrosis was not aggravated by the high-cholesterol diet in C3H/HeJ mice, which express a mutant form of TLR4; HSCs that express mutant TLR4 were not activated by accumulation of free cholesterol.Conclusions Dietary cholesterol aggravates liver fibrosis because free cholesterol accumulates in HSCs, leading to increased TLR4 signaling, down-regulation of bone morphogenetic protein and activin membrane-bound inhibitor, and sensitization of HSC to TGFβ. This pathway might be targeted by antifibrotic therapies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2011.09.049

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,687
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis
Malhi, H., Bronk, S. F., Werneburg, N. W., & Gores, G. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510660200 · Cited by 724
Toll-Like Receptor 4 Mediates Inflammatory Signaling by Bacterial Lipopolysaccharide in Human Hepatic Stellate Cells
Paik, Y.-H., Schwabe, R. F., Bataller, R., Russo, M. P., Jobin, C., & Brenner, D. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50182 · Cited by 651
Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis
Marí, M., Caballero, F. G., Colell, A., Morales, A., Caballería, J., Fernandez, A., Enrich, C., Fernández-Checa, J. C., & García‐Ruiz, C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.07.006 · Cited by 624
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis†
Wouters, K., van Gorp, P. J., Bieghs, V., Gijbels, M. J., Duimel, H., Lütjohann, D., Kerksiek, A., van Kruchten, R., Maeda, N., Staels, B., et al. (2008) · Hepatology · doi:10.1002/hep.22363 · Cited by 482
Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice
Tomita, K., Tamiya, G., Ando, S., Ohsumi, K., Chiyo, T., Mizutani, A., Kitamura, N., Toda, K., Kaneko, T., Horie, Y., et al. (2005) · Gut · doi:10.1136/gut.2005.071118 · Cited by 454
Self-citation
Free Cholesterol-loaded Macrophages Are an Abundant Source of Tumor Necrosis Factor-α and Interleukin-6
Li, Y., Schwabe, R. F., DeVries-Seimon, T., Yao, P. M., Gerbod-Giannone, M.-C., Tall, A. R., Davis, R. J., Flavell, R., Brenner, D. A., & Tabas, I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501759200 · Cited by 421
Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.013 · Cited by 272
Cholesterol Accumulation Is Associated with Lysosomal Dysfunction and Autophagic Stress in Npc1−/− Mouse Brain
Liao, G., Yao, Y., Liu, J., Yu, Z., Cheung, S., Xie, A., Liang, X., & Bi, X. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070052 · Cited by 220

Show all 23 references

Research works printed but not linked: 2

Paik, 2003, Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells, Hepatology, 37, 1043, 10.1053/jhep.2003.50182 · DOI · Paper page
Seki, 2007, TLR4 enhances TGF-beta signaling and hepatic fibrosis, Nat Med, 13, 1324, 10.1038/nm1663 · DOI · Paper page

Sorted by citations

Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
Immunology in the liver — from homeostasis to disease
Heymann, F., & Tacke, F. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.200 · Cited by 1,180
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Parola, M., & Pinzani, M. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.09.002 · Cited by 1,217
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Marra, F., & Svegliati-Baroni, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.014 · Cited by 847
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Schwabe, R. F., Tabas, I., & Pajvani, U. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.311 · Cited by 671
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
Hardy, T., Oakley, F., Anstee, Q. M., & Day, C. P. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044224 · Cited by 641
The Role of Cholesterol in the Pathogenesis of NASH
Ioannou, G. N. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.11.008 · Cited by 498
Metabolic reprogramming in liver fibrosis
Horn, P., & Tacke, F. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.003 · Cited by 432
The Power of Plasticity—Metabolic Regulation of Hepatic Stellate Cells
Trivedi, P., Wang, S., & Friedman, S. L. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.026 · Cited by 427
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Wang, X., Zheng, Z., Caviglia, J. M., Corey, K. E., Herfel, T. M., Cai, B., Masia, R., Chung, R. T., Lefkowitch, J. H., Schwabe, R. F., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.016 · Cited by 413
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
Musso, G., Gambino, R., & Cassader, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.11.002 · Cited by 415
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
Gorden, D. L., Myers, D. S., Ivanova, P. T., Fahy, E., Maurya, M. R., Gupta, S., Min, J., Spann, N. J., McDonald, J. G., Kelly, S. L., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p056002 · Cited by 372
Free cholesterol accumulation in hepatic stellate cells: Mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice
Tomita, K., Teratani, T., Suzuki, T., Shimizu, M., Sato, H., Narimatsu, K., Okada, Y., Kurihara, C., Irie, R., Yokoyama, H., et al. (2014) · Hepatology · doi:10.1002/hep.26604 · Cited by 315
Self-citation
Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
Argüello, G., Balboa, E., Arrese, M. A., & Zanlungo, S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.015 · Cited by 320
Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches
Schuppan, D., & Schattenberg, J. M. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12212 · Cited by 256
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease
Svegliati‐Baroni, G., Pierantonelli, I., Torquato, P., Marinelli, R., Ferreri, C., Chatgilialoglu, C., Bartolini, D., & Galli, F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.029 · Cited by 255
Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis
Li, H., Yu, X.-H., Ou, X., Ouyang, X.-P., & Tang, C. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101109 · Cited by 237
Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
Khomich, O. A., Ivanov, A. V., & Bartosch, B. (2019) · Cells · doi:10.3390/cells9010024 · Cited by 239
Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH
Horn, C. L., Morales, A. L., Savard, C. E., Farrell, G. C., & Ioannou, G. N. (2021) · Hepatology Communications · doi:10.1002/hep4.1801 · Cited by 224
Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis
Wang, X., Cai, B., Yang, X., Sonubi, O. O., Zheng, Z., Ramakrishnan, R., Shi, H., Valenti, L., Pajvani, U. B., Sandhu, J., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.010 · Cited by 204
Mitochondrial cholesterol: Metabolism and impact on redox biology and disease
Goicoechea, L., de la Rosa, L. C., Torres, S., García‐Ruiz, C., & Fernández-Checa, J. C. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102643 · Cited by 196
Pathophysiological mechanisms underlying MAFLD
Kuchay, M. S., Choudhary, N. S., & Mishra, S. K. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.09.026 · Cited by 188
Toll-Like Receptors in Liver Fibrosis: Cellular Crosstalk and Mechanisms
Yang, L., & Seki, E. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00138 · Cited by 184
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158
Metabolic liver disease in diabetes – From mechanisms to clinical trials
Dewidar, B., KAHL, S., Pafili, K., & Roden, M. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154299 · Cited by 167
Diet associations with nonalcoholic fatty liver disease in an ethnically diverse population: the multiethnic cohort
Noureddin, M., Zelber‐Sagi, S., Wilkens, L. R., Porcel, J., Boushey, C. J., Le Marchand, L., Rosen, H. R., & Setiawan, V. W. (2020) · Hepatology · doi:10.1002/hep.30967 · Cited by 148
The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial
Takeshita, Y., Takamura, T., Honda, M., Kita, Y., Zen, Y., Kato, K., Misu, H., Ota, T., Nakamura, M., Yamada, K., et al. (2014) · Diabetologia · doi:10.1007/s00125-013-3149-9 · Cited by 137
Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis
Jiang, Y., Xiang, C., Zhong, F., Zhang, Y., Wang, L., Zhao, Y., Wang, J., Ding, C., Li, J., He, F., et al. (2020) · Theranostics · doi:10.7150/thno.46360 · Cited by 124
Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis
Liu, H., Pathak, P., Boehme, S., & Chiang, J. Y. L. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m069807 · Cited by 125
MASH: the nexus of metabolism, inflammation, and fibrosis
Steinberg, G. R., Carpentier, A. C., & Wang, D. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186420 · Cited by 135
Role of Metabolism in Hepatic Stellate Cell Activation and Fibrogenesis
Hou, W., & Syn, W. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00150 · Cited by 121
Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway
Liu, M., Xu, Y., Han, X., Yin, L., Xu, L., Qi, Y., Zhao, Y., Liu, K., & Peng, J. (2015) · Scientific Reports · doi:10.1038/srep18038 · Cited by 120
MCJ/DnaJC15, an Endogenous Mitochondrial Repressor of the Respiratory Chain That Controls Metabolic Alterations
Hatle, K. M., Gummadidala, P. M., Navasa, N., Bernardo, E., Dodge, J. T., Silverstrim, B., Fortner, K. A., Burg, E., Suratt, B. T., Hammer, J., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00189-13 · Cited by 117
Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis—Roles as Putative Treatment Targets?
Zisser, A., Ipsen, D. H., & Tveden‐Nyborg, P. (2021) · Biomedicines · doi:10.3390/biomedicines9040365 · Cited by 112
Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
Chen, Z., Jain, A., Liu, H., Zhao, Z., & Cheng, K. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.256156 · Cited by 105
Stellate Cells in Tissue Repair, Inflammation, and Cancer
Sherman, M. H. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100617-062855 · Cited by 104
Nlrp3 is a key modulator of diet-induced nephropathy and renal cholesterol accumulation
Bakker, P. J., Butter, L. M., Kors, L., Teske, G. J. D., Aten, J., Sutterwala, F. S., Florquin, S., & Leemans, J. C. (2013) · Kidney International · doi:10.1038/ki.2013.503 · Cited by 98
Acyl-CoA:cholesterol acyltransferase 1 mediates liver fibrosis by regulating free cholesterol accumulation in hepatic stellate cells
Tomita, K., Teratani, T., Suzuki, T., Shimizu, M., Sato, H., Narimatsu, K., Usui∥, S., Furuhashi, H., Kimura, A., Nishiyama, K., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.018 · Cited by 96
Self-citation
Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease
Kuchay, M. S., Choudhary, N. S., & Ramos‐Molina, B. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00951.2024 · Cited by 104
High‐fat and high‐cholesterol diet rapidly induces non‐alcoholic steatohepatitis with advanced fibrosis in S prague– D awley rats
Ichimura‐Shimizu, M., Kawase, M., Masuzumi, M., Sakaki, M., Nagata, Y., Tanaka, K., Suruga, K., Tamaru, S., Kato, S., Tsuneyama, K., et al. (2014) · Hepatology Research · doi:10.1111/hepr.12358 · Cited by 88
Potential for Dietary ω-3 Fatty Acids to Prevent Nonalcoholic Fatty Liver Disease and Reduce the Risk of Primary Liver Cancer
Jump, D. Β., Depner, C. M., Tripathy, S., & Lytle, K. A. (2015) · Advances in Nutrition · doi:10.3945/an.115.009423 · Cited by 84
The role of iNOS in cholesterol-induced liver fibrosis
Anavi, S., Eisenberg‐Bord, M., Hahn-Obercyger, M., Genin, O., Pines, M., & Tirosh, O. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.67 · Cited by 80
Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease
Wiering, L., Subramanian, P., & Hammerich, L. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.02.010 · Cited by 80
Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression
Tirosh, O. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2548154 · Cited by 77
Diagnosis and treatment of nutritional deficiencies in alcoholic liver disease: Overview of available evidence and open issues
Rossi, R. E., Conte, D., & Massironi, S. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.05.021 · Cited by 77
Targeting cell-intrinsic metabolism for antifibrotic therapy
Gilgenkrantz, H., Mallat, A., Moreau, R., & Lotersztajn, S. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.012 · Cited by 76
Nutrition in Alcoholic Liver Disease
Singal, A. K., & Charlton, M. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.08.009 · Cited by 76
BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration
Herrera, B. M., Addante, A., & Sánchez, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010039 · Cited by 79
Very-low-density lipoprotein receptor-enhanced lipid metabolism in pancreatic stellate cells promotes pancreatic fibrosis
Yang, X., Chen, J., Wang, J., Ma, S., Feng, W., Wu, Z., Guo, Y., Zhou, H., Mi, W., Chen, W., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.06.001 · Cited by 70
Liver X Receptors Regulate Cholesterol Metabolism and Immunity in Hepatic Nonparenchymal Cells
Endo‐Umeda, K., & Makishima, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205045 · Cited by 68
Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era?
Chan, Y.-T., Wang, N., Tan, H. Y., Li, S., & Feng, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00548 · Cited by 63
Combining streptozotocin and unilateral nephrectomy is an effective method for inducing experimental diabetic nephropathy in the ‘resistant’ C57Bl/6J mouse strain
Uil, M., Scantlebery, A. M. L., Butter, L. M., Larsen, P. W. B., de Boer, O. J., Leemans, J. C., Florquin, S., & Roelofs, J. J. T. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-23839-9 · Cited by 61
Mirtoselect, an anthocyanin-rich bilberry extract, attenuates non-alcoholic steatohepatitis and associated fibrosis in ApoE∗3Leiden mice
Morrison, M. C., Liang, W., Mulder, P., Verschuren, L., Pieterman, E. J., Toet, K. H., Heeringa, P., Wielinga, P. Y., Kooistra, T., & Kleemann, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.011 · Cited by 61
Fibrotic Events in the Progression of Cholestatic Liver Disease
Wu, H., Chen, C., Ziani, S., Nelson, L. J., Avila, M. A., Nevzorova, Y. A., & Cubero, F. J. (2021) · Cells · doi:10.3390/cells10051107 · Cited by 62
The Space of Disse: The Liver Hub in Health and Disease
Sanz-García, C., Fernández-Iglesias, A., Gracia-Sancho, J., Arráez-Aybar, L. A., Nevzorova, Y. A., & Cubero, F. J. (2021) · Livers · doi:10.3390/livers1010002 · Cited by 57
Non‐alcoholic fatty liver disease
Tuyama, A. C., & Chang, C. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2012.00204.x · Cited by 58
Lipoprotein Lipase Up‐regulation in Hepatic Stellate Cells Exacerbates Liver Fibrosis in Nonalcoholic Steatohepatitis in Mice
Teratani, T., Tomita, K., Furuhashi, H., Sugihara, N., Higashiyama, M., Nishikawa, M., Irie, R., Takajo, T., Wada, A., Horiuchi, K., et al. (2019) · Hepatology Communications · doi:10.1002/hep4.1383 · Cited by 56
Self-citation
Cholesterol and nonalcoholic fatty liver disease: Renewed focus on an old villain
Kerr, T. A., Davidson, N. O., Groszmann, R. J., Iwakiri, Y., & Taddei, T. H. (2012) · Hepatology · doi:10.1002/hep.26088 · Cited by 55
Diabetes as a risk factor for MASH progression
Gancheva, S., Roden, M., & Castéra, L. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111846 · Cited by 60
Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high‐fat diet
Miura, K., Ohnishi, H., Morimoto, N., Minami, S., Ishioka, M., Watanabe, S., Tsukui, M., Takaoka, Y., Nomoto, H., Isoda, N., et al. (2018) · Cancer Science · doi:10.1111/cas.13902 · Cited by 54
Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH
Itoh, M., Tamura, A., KANAI, S., Tanaka, M., Kanamori, Y., Shirakawa, I., Ito, A., Oka, Y., Hidaka, I., Takami, T., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20220681 · Cited by 52
Simvastatin inhibits hepatic stellate cells activation by regulating the ferroptosis signaling pathway
Kitsugi, K., Noritake, H., Matsumoto, M., Hanaoka, T., Umemura, M., Yamashita, M., Takatori, S., Ito, J., Ohta, K., Chida, T., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166750 · Cited by 53
Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs)
Okazaki, I., Noro, T., Tsutsui, N., Yamanouchi, E., Kuroda, H., Nakano, M., Yokomori, H., & Inagaki, Y. (2014) · Cancers · doi:10.3390/cancers6031220 · Cited by 55
Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis
Noureddin, M., Anstee, Q. M., & Loomba, R. S. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13620 · Cited by 50
The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis
Du, W., & Wang, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.936196 · Cited by 53
Non-alcoholic fatty liver disease: What has changed in the treatment since the beginning?
Baran, B. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14219 · Cited by 51
Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling
Ducheix, S., Montagner, A., Polizzi, A., Lasserre, F., Régnier, M., Marmugi, A., Benhamed, F., Bertrand‐Michel, J., Mselli-Lakhal, L., Loiseau, N., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181393 · Cited by 53
Chitinase 3‐like 1 deficiency ameliorates liver fibrosis by promoting hepatic macrophage apoptosis
Higashiyama, M., Tomita, K., Sugihara, N., Nakashima, H., Furuhashi, H., Nishikawa, M., Inaba, K., Wada, A., Horiuchi, K., Hanawa, Y., et al. (2019) · Hepatology Research · doi:10.1111/hepr.13396 · Cited by 50
Self-citation
Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: Non-invasive identification and treatment monitoring by magnetic resonance
Thelwall, P. E., Smith, F. E., Leavitt, M. C., Canty, D. J., Hu, W., Hollingsworth, K. G., Thoma, C., Trenell, M. I., Taylor, R., Rutkowski, J. V., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.016 · Cited by 45
NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook
Nascè, A., Gariani, K., Jornayvaz, F. R., & Szántó, I. (2022) · Antioxidants · doi:10.3390/antiox11061131 · Cited by 49
Liver X Receptor Inverse Agonist SR9243 Suppresses Nonalcoholic Steatohepatitis Intrahepatic Inflammation and Fibrosis
Huang, P., Kaluba, B., Jiang, X.-L., Chang, S., Tang, X.-F., Mao, L.-F., Zhang, Z.-P., & Huang, F.-Z. (2018) · BioMed Research International · doi:10.1155/2018/8071093 · Cited by 44
Targeting fatty acid metabolism for fibrotic disorders
Hwang, S., & Chung, K. W. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01352-4 · Cited by 47
Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease
Kotlyarov, S. N., & Bulgakov, A. (2021) · Cells · doi:10.3390/cells10112978 · Cited by 45
Long-Term Exposure to Low-Dose Di-(2-ethylhexyl) Phthalate Impairs Cholesterol Metabolism in Hepatic Stellate Cells and Exacerbates Liver Fibrosis
Lee, C.-Y., Suk, F., Twu, Y., & Liao, Y. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17113802 · Cited by 43
Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms
Shaaban, H. H., AlZaim, I., El‐Mallah, A., Aly, R. G. M., EL‐Yazbi, A. F., & Wahid, A. M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120956 · Cited by 42
Gut microbiota combined with metabolomics reveal the mechanism of curcumol on liver fibrosis in mice
Zheng, Y., Wang, J., Wang, J., 姜瑞祝, Liang, T., & Zhao, T. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113204 · Cited by 41
Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy
Kanno, K., Koseki, M., Chang, J., Saga, A., Inui, H., Okada, T., Tanaka, K., Asaji, M., Zhu, Y., Ide, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-06542-8 · Cited by 44
Epigenetic modifications by histone deacetylases: Biological implications and therapeutic potential in liver fibrosis
Chen, P., Huang, C., Meng, X., & Li, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.06.016 · Cited by 41
Lipidomic profiling of rat hepatic stellate cells during activation reveals a two-stage process accompanied by increased levels of lysosomal lipids
Molenaar, M. R., Haaker, M. W., Vaandrager, A. B., Houweling, M., & Helms, J. B. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.103042 · Cited by 41
Cholesterol Induces Nrf-2- and HIF-1 α-Dependent Hepatocyte Proliferation and Liver Regeneration to Ameliorate Bile Acid Toxicity in Mouse Models of NASH and Fibrosis
Kaminsky-Kolesnikov, Y., Rauchbach, E., Abu-Halaka, D., Hahn, M., García-Ruiz, C., Fernandez-Checa, J. C., Madar, Z., & Tirosh, O. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5393761 · Cited by 39
PNPLA3 I148M variant impairs liver X receptor signaling and cholesterol homeostasis in human hepatic stellate cells
Bruschi, F. V., Claudel, T., Tardelli, M., Starlinger, P., Marra, F., & Trauner, M. (2019) · Hepatology Communications · doi:10.1002/hep4.1395 · Cited by 38
Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats
Gerges, S. H., Wahdan, S. A., Elsherbiny, D. A., & El‐Demerdash, E. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115101 · Cited by 39
TM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver Disease
Chen, L., Xia, H. H., Xin, Y., Lin, Z., & Xuan, S. (2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2015.00023 · Cited by 38
Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease
Zhang, H., Léveillé, M., Courty, É., Güneş, A., Nguyen, B., & Estall, J. L. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00321.2020 · Cited by 35
Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH
Traussnigg, S., Kienbacher, C., Halilbasic, E., Rechling, C., Kazemi-Shirazi, L., Hofer, H., Munda, P., & Trauner, M. A. (2015) · Digestive Diseases · doi:10.1159/000375353 · Cited by 37
Cholesterol Induces Oxidative Stress, Mitochondrial Damage and Death in Hepatic Stellate Cells to Mitigate Liver Fibrosis in Mice Model of NASH
Rauchbach, E., Zeigerman, H., Abu-Halaka, D., & Tirosh, O. (2022) · Antioxidants · doi:10.3390/antiox11030536 · Cited by 36
Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr−/− mice
Jump, D. Β., Depner, C. M., Tripathy, S., & Lytle, K. A. (2015) · Proceedings of The Nutrition Society · doi:10.1017/s002966511500244x · Cited by 36
Free cholesterol accumulation in liver sinusoidal endothelial cells exacerbates acetaminophen hepatotoxicity via TLR9 signaling
Teratani, T., Tomita, K., Suzuki, T., Furuhashi, H., Irie, R., Hida, S., Okada, Y., Kurihara, C., Ebinuma, H., Nakamoto, N., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.020 · Cited by 38
Self-citation
Understanding and Treating Niemann–Pick Type C Disease: Models Matter
Pallottini, V., & Pfrieger, F. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238979 · Cited by 40
Vitamin A‐coupled liposome system targeting free cholesterol accumulation in hepatic stellate cells offers a beneficial therapeutic strategy for liver fibrosis
Furuhashi, H., Tomita, K., Teratani, T., Shimizu, M., Nishikawa, M., Higashiyama, M., Takajo, T., Shirakabe, K., Maruta, K., Okada, Y., et al. (2017) · Hepatology Research · doi:10.1111/hepr.13040 · Cited by 34
Self-citation
Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population
Pillai, S. S., Lakhani, H. V., Zehra, M., Wang, J., Dilip, A., Puri, N., O'Hanlon, K. M., & Sodhi, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186698 · Cited by 34
Elevation of plasma tRNA fragments as a promising biomarker for liver fibrosis in nonalcoholic fatty liver disease
Huang, P. F., Tu, B., Liao, H.-J., Huang, F., Li, Z., Zhu, K.-Y., Dai, F., Liu, H.-Z., Zhang, T.-Y., & Sun, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-85421-0 · Cited by 34
When GLP-1 hits the liver: a novel approach for insulin resistance and NASH
Kim, Y. O., & Schuppan, D. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00078.2012 · Cited by 34
Lipids in Liver Disease: Looking Beyond Steatosis
Schwabe, R. F., & Maher, J. J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.11.004 · Cited by 33
Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease
Kim, H.-J., Park, C., & Kim, T. H. (2023) · Cells · doi:10.3390/cells12091292 · Cited by 34
Cell metabolism-based therapy for liver fibrosis, repair, and hepatocellular carcinoma
Gilgenkrantz, H., Paradis, V., & Lotersztajn, S. (2023) · Hepatology · doi:10.1097/hep.0000000000000479 · Cited by 31
Dietary macro and micronutrients associated with MASLD: Analysis of a national US cohort database
Nemer, M., Osman, F., & Said, A. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101491 · Cited by 36
Immunoregulation by lipids during the development of non-alcoholic steatohepatitis.
Ramadori, P., Kroy, D. C., & Streetz, K. L. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2015.01.02 · Cited by 31
From Liver Fat to Cancer: Perils of the Western Diet
Kim, J. Y., He, F., & Karin, M. (2021) · Cancers · doi:10.3390/cancers13051095 · Cited by 32

Authors: Teratani, T., Tomita, K., Suzuki, T., Oshikawa, T., Yokoyama, H., Shimamura, K., Tominaga, S., Hiroi, S., Irie, R., Okada, Y., Kurihara, C., Ebinuma, H., Saito, H., Hokari, R., Sugiyama, K., Kanai, T., Miura, S., & Hibi, T.
Affiliations: Keio University (JP)
National Defense Medical College (JP)
Kawasaki Municipal Hospital (JP)
Corresponding author: Tomita, Kengo
ORCID: Tomita, Kengo
Suzuki, Takahiro
Irie, Rie
Okada, Yoshikiyo
Kurihara, Chie
Ebinuma, Hirotoshi
Saito, Hidetsugu
Hokari, Ryota
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2012-01
Volume: 142
Issue: 1
Pages: 152-164.e10
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2011.09.049
OpenAlex: W1996266503
Cited by: 241
References: 23
Citations by year: 2026: 15 · 2025: 21 · 2024: 22 · 2023: 25 · 2022: 22 · 2021: 15 · 2020: 20 · 2019: 14 · 2018: 13 · 2017: 8 · 2016: 19 · 2015: 16 · 2014: 7 · 2013: 14 · 2012: 9
FWCI: 6.22
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
Funders: Ministry of Education, Culture, Sports, Science and Technology
Topics: Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: dietary cholesterol, liver fibrosis, hepatic stellate cells, free cholesterol accumulation, TLR4, TGF-beta signaling, Niemann-Pick C1, bile duct ligation, carbon tetrachloride, hepatic fibrogenesis, antifibrotic therapy
MeSH terms: Niemann-Pick C1 Protein, Animals, Bile Ducts, Carbon Tetrachloride, Cholesterol, Dietary, Disease Models, Animal, Kupffer Cells, Ligation, Liver Cirrhosis, Male, Membrane Proteins, Mice, Inbred C3H, Mice, Inbred C57BL, Proteins, Time Factors, Signal Transduction, Transforming Growth Factor beta, Apoptosis, Mice, Knockout, Disease Progression, Intracellular Signaling Peptides and Proteins, Toll-Like Receptor 4, Mice, Niemann-Pick Disease, Type C, Hepatic Stellate Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A High-Cholesterol Diet Exacerbates Liver Fibrosis in Mice via Accumulation of Free Cholesterol in Hepatic Stellate Cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks